Citations

Clear

100 citation(s) found for "Satish, S".

A novel classification of testicular sex cord‐stromal tumours from the Testicular Sex Cord‐Stromal Tumour ( TESST ) group: a collaboration of the Genitourinary Pathology Society (
Acosta, Andrés , Bremmer, Felix , Jc, Cheville, Colecchia, Maurizio , Comperat, Eva, Cornejo, Kristine, Baydar, Dilek E., Gill, A J, Gonzalez‐Peramato, Maria del Pilar, Gupta, Sounak , Hirsch, Michelle S. , Idrees, Muhammad T., Maclean, Fiona, Mohanty, Sambit K., Raspollini, Maria Rosaria , Sangoi, Ankur R , SHOLL, L B, Siegmund, S, Tickoo, Satish K., Tm, Ulbright, Yilmaz, Asli, Sangoi, Ankur R. , Acosta, Andrés M , Matoso, Andres , Menon, Santosh , Michalova, Kvetoslava , Reyes-Mugica, Miguel , Raspollini, Maria Rosaria , Sangoi, Ankur R , Tsuzuki, Toyonori , Berney, Daniel M , Sangoi, Ankur R , Compérat, Éva , Cornejo, Kristine M. , Baydar, Dilek Ertoy , González-Peramato, María Pilar, Idrees, Muhammad T. , Kao, Chia‐Sui , Maclean, Fiona M. , Mehra, Rohit, Mohanty, Sambit K. , Reyes‐Múgica, Miguel , Siegmund, Sophie C., Tickoo, Satish K. , Tsuzuki, Toyonori , Ulbright, Thomas M. , Williamson, Sean R. , Yilmaz, Aslı , Berney, Daniel M.

Mayo Clinic

Histopathology | July 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/his.70207 | PMID 42421431 Get It

Aims Testicular sex cord‐stromal tumours (TSCSTs) are rare neoplasms that arise from (or show differentiation to) elements derived from the sex cords or intertubular stroma. The current classification (World Health Organization, 2022) is based almost entirely on morphology, with many tumour types such as granulosa cell tumours being defined based on their resemblance to ovarian counterparts. Recent studies have uncovered new clinicopathological, molecular and biological nuances within this group of tumours, underscoring differences with ovarian homologues. Methods and results Considering the new data, a group of genitourinary pathology experts (Testicular Sex Cord‐Stromal Tumour [TESST] group) has proposed a revised ‘TESST classification’ that incorporates the best available evidence. This classification is structured and hierarchical, composed of the following tiers: (1) group, (2) category, (3) entity and (4) histological pattern. ‘Group’ refers to the histological compartment a specific tumour belongs to (sex cords, stroma or both), whereas ‘category’ is defined by the phenotype of the tumour, taking non‐neoplastic elements of the ovary and testis as a reference. The third tier, ‘entity’, refers to neoplasms with shared clinicopathological and/or molecular features that justify classifying them as distinct types. Lastly, ‘histological patterns’ are recurrent morphological variations within entities that are not linked to distinct clinicopathological or molecular features. Conclusions We propose a classification that will provide a framework to improve current clinical management and guide future research in the field.
Development of a Computed Tomography Enterography-Based Radiomics Model to Characterize Inflammation, Fibrosis, and Smooth Muscle Thickening in Stricturing Crohn's Disease
Sleiman, Joseph , Pillai, Gargi V. , Chirra, Prathyush , Gandhi, Namita , Gordon, Ilyssa O. , Hariri, Mohsen , Baker, Mark E. , Ream, Justin , Fulmer, Clifton G. , Ouali, Sara El , Bruining, David H., Rieder, Florian, Gandhi, Namita S , Fulmer, Clifton , El Ouali, Sara , Kurowski, Jacob A , Viswanath, Satish E , Sleiman, Joseph , Gordon, Ilyssa O , Baker, Mark E , Bruining, David H. , Rieder, Florian

Mayo Clinic

American Journal of Gastroenterology | June 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.14309/ajg.0000000000004073 | PMID 42262346 Get It

INTRODUCTION: Computed tomography enterography (CTE) is a noninvasive cross-sectional imaging modality routinely used for diagnosis of Crohn's disease (CD) strictures. However, CTE is limited in individually defining the severity of inflammation, fibrosis, or smooth muscle hyperplasia/hypertrophy (SMH) within such strictures. We developed and internally validated a radiomics-based machine learning model for separately characterizing the degree of histopathological inflammation, fibrosis, and SMH in CD strictures and compared it with centrally read visual radiologist scoring of CTE. METHODS: This single-center, cross-sectional study included 100 patients with CD (n = 66 for discovery; n = 34 for validation) with terminal ileal strictures confirmed on diagnostic CTE within 15 weeks of intestinal resection. Histopathological specimens were scored for inflammation, fibrosis, and SMH and spatially linked with corresponding pre-surgical CTE sequences. Annotated stricture regions on CTE were scored visually by radiologists as well as underwent three-dimensional radiomics-based machine-learning analysis; both evaluated against histopathology scoring. RESULTS: Three distinct sets of radiomic features capturing textural heterogeneity within strictures were separately linked with severe inflammation, fibrosis, and SMH across both discovery (accuracy = 0.74, 0.71, 0.71, respectively) and validation (accuracy = 0.74, 0.68, 0.68, respectively) cohorts. Radiologist visual scoring was limited, with accuracy of 0.51 for identifying severe inflammation, 0.48 for severe fibrosis, and 0.58 for severe SMH. Augmenting radiologist scoring with radiomic features yielded improved performance in identifying severe inflammation, fibrosis, or SMH compared to radiologist scoring alone. DISCUSSION: Radiomic features of CD strictures on CTE can identify severe histopathological fibrosis, inflammation, and smooth muscle hyperplasia and perform better than radiologist visual scoring in stricture characterization.
Real World Analysis of Machine Perfusion in Liver Transplantation – An International Cohort Study
Pfister, M, Eden, J, Rasel, H, Abbassi, F, Botea, F, Buchholz, B, Camagni, S, Chapman, W, Cillo, U, Cimeno, A, Compagnon, P, Croome, K, Carlis, R de, Diogo, D, Dondossola, D, Fung, J, Fronek, J, Garcia, C, Györi, G, Koliogiannis, D, Lam, H D, Lurje, G, Magistri, P, Monbaliu, D, Patel, M, Patrono, D, Porte, R, Ravaioli, M, Rayar, M, Satish, S, Schlegel, A, Shapiro, J, Sörensen, G, Vaccharajani, N, Vagefi, P, Pinna, A, Dutkowski, P, Meijer, V de, Clavien, P A, Pfister, Matthias , Eden, Janina , Rasel, Hannah, Abbassi, Fariba , Botea, Florin , Buchholz, Bettina M. , Camagni, Stefania , Cimeno, Arielle , Compagnon, Philippe , Croome, Kristopher P. , Carlis, Riccardo De , Diogo, D. , Dondossola, Daniele Eliseo , Froněk, Jiří , Györi, Georg, Koliogiannis, Dionysios , Lam, Hwai‐Ding , Lurje, Georg , Magistri, Paolo , Monbaliu, Diethard , Patel, Madhukar S. , Patrono, Damiano , Ravaioli, Matteo , Rayar, Michel , Schlegel, Andrea , Shapiro, A. M. James , Sörensen, Gustaf, Vaccharajani, N., Vagefi, Parsia A. , Dutkowski, Philipp , Meijer, Vincent Erwin de

Mayo Clinic

British Journal of Surgery | June 3, 2026 | Volume: 113 | Issue: Supplement_5 | Pages: No page available

10.1093/bjs/znag055.059 Get It

Abstract Background Machine perfusion represents the most significant breakthrough in liver transplantation (LT) since the discovery of cyclosporin. Yet, the optimal perfusion strategy remains unsettled. Randomized trials demonstrate that hypothermic oxygenated perfusion (HOPE) improves graft survival and function and reduces ischemic cholangiopathy, whereas normothermic machine perfusion (NMP) decreases post-transplant injury. Real-world comparisons are lacking and challenging due to heterogeneity in donor-recipient risk profiles and regional differences. Aims To compare real-world outcomes of HOPE and NMP in LT. Methods We analyzed consecutive NMP-preserved LTs from seven North American centers between 2021 and 2024. We compared NMP to the European HOPE-REAL cohort, comprising HOPE-treated LTs from 22 centers between 2012 and 2021. Analyses were stratifyied by graft type and risk category and adjusted for donor age, donor risk index, and balance of risk score using entropy balancing. Results A total of 470 NMP and 1202 HOPE-treated grafts were analyzed, revealing major differences in risk profiles (Figure 1). In NMP, death-censored graft survivals at 1, 2, and 3 years were >95% in donation after brain death (DBD) and >94% in donation after circulatory death (DCD) grafts. Comparable outcomes were observed in the HOPE cohort with >93%, in DBD, and >87% in DCD after up to 3 years, despite significantly higher donor age and longer functional warm ischemia in the HOPE DCD cohort (Figure 2). After risk adjustment, death-censored graft survival remained similar between both modalities (Table 1). Non-anastomotic biliary stricture rates after DCD-LT were comparable (8.5% vs. 12.4%), independent of whether continuous or end-ischemic NMP was performed. Conclusion This first transatlantic real-world report demonstrates excellent outcomes with both NMP and HOPE despite higher graft risk in Europe. Machine perfusion is the new standard of care in LT, while further understanding is needed regarding the distinct benefits of each modality across risk profiles.Figure 1.Graft risk in NMP and HOPE stratified by graft type. Benchmark case was defined as primary transplant with MELD <20 and BAR score <9, extended criteria as either BMI >30kg/m2, donor age >65 years, CIT >12h. DCD grafts were categorized as definedFor image description, please refer to the figure legend and surrounding text. Figure 2.Death-censored graft survival in liver transplantation following NMP and HOPE stratified by graft type. Abbreviations: NMP (Normothermic Machine Perfusion), HOPE (Hypothermic Oxygenated Perfusion), DBD (Donation after Brain Death), DCD (Donation after circulatory death)For image description, please refer to the figure legend and surrounding text. Table 1.Risk-adjusted comparison of death-censored graft survival between NMP and HOPE.For image description, please refer to the figure legend and surrounding text.
Portal-Venous Hypothermic Oxygenated Perfusion for Liver Transplant
Reich, David J. , Mao, Shennen, Satish, Sangeeta , Nassar, Ahmed, Rizzari, Michael, Al‐Adra, David , Woloszyn, Jakub, Doyle, M.B. Majella, Bohórquez, Humberto, Mihaylov, Plamen, Saharia, Ashish, Wehrle, Chase J., Miller, Charles, Axelrod, David, An, Langnas, Melcher, Marc L., Akoad, Mohamed, Ghobrial, R. Mark , Kubal, Chandrashekhar, Roll, Garrett, Cohen, Ari, Chapman, William C., Pinna, Antonio, Vera, Michael de , Florman, Sander, Foley, David P. , Abouljoud, Marwan, Quintini, Cristiano , Hashimoto, Koji, Croome, Kristopher, Taner, C. Burin, Schlegel, Andrea, Schlegel, Andrea , Taner, C. Burcin , Schlegel, Andrea , Nassar, Ahmed , Rizzari, Michael D. , DiNorcia, Joseph , Bohorquez, Humberto E. , Mihaylov, Plamen , Saharia, A., Merani, Shaheed , Wehrle, Chase J. , Miller, Charles , Axelrod, David A. , Langnas, Alan N. , Melcher, Marc L. , Akoad, Mohamed Elhassan , Kubal, Chandrashekhar A. , Roll, Garrett Richard , Chapman, William C. , Pinna, Antonio D., Vera, Michael E. de , Abouljoud, Marwan , Hashimoto, Koji, Croome, Kristopher P.

Mayo Clinic

JAMA Surgery | May 27, 2026 | Volume: 161 | Issue: 7 | Pages: 691

10.1001/jamasurg.2026.1604 | PMID 42201712 Get It

Importance Ischemia-reperfusion injury contributes to graft dysfunction after liver transplant. Hypothermic oxygenated perfusion (HOPE) has been shown to improve liver function, but its benefit in extended criteria donors in a US population remains unclear. Objective To assess whether back-to-base portal-venous HOPE impacts outcomes after liver transplant in the US. Design, Setting, and Participants The Bridge to HOPE Trial is a multicenter, randomized, open-label trial with 1-year follow-up. The study took place at 15 US liver transplant centers and patients were enrolled between January 2021 and May 2023. Central assessment of complications and cholangiograms for nonanastomotic biliary strictures (NAS) was blinded to treatment arm. Participants included 219 recipients of extended-criteria donor livers after brain death (DBD) and after circulatory death (DCD) who were randomized 1:1 to HOPE after static cold storage (SCS) (n = 109) or SCS only (n = 110). Randomization was performed after liver inspection and acceptance for transplant. Data were analyzed from December 2024 to July 2025. Intervention After SCS and transport, livers underwent portal-venous HOPE until implant, using the VitaSmart HOPE System. Main Outcomes and Measures The primary efficacy end point was early allograft dysfunction (EAD). Other main outcomes included model for early allograft function (MEAF) score, hospital length of stay (LOS), patient and graft survival, and biliary complications. Additional post hoc analyses were performed. Results Overall, 219 patients (82 female [37.4%] and 137 male[62.6%]) were included (DCD, 57 of 219 [26%]) with 97% (212 of 219) completing 12-month follow-up. EAD incidence was 20.2% (22 of 109) with HOPE vs 37.3% (41 of 110) with SCS (rate difference, −17.1%; 95% CI, −27.2 to −7.0; noninferiority P < .001; superiority P = .005). HOPE treatment led to significantly lower MEAF mean (SD) scores (HOPE group, 4.28 [1.75]; control group, 4.82 [1.85]; mean difference, −0.54; 95% CI, −1.02 to −0.06; P = .03) and shorter median LOS (hazard ratio, 1.32; 95% CI, 1.01-1.73; P = .04). NAS on imaging and 1-year survivals were comparable between groups (patients: HOPE group, 106 of 109 [97.2%] vs SCS, 106 of 110 [96.4%]; graft: HOPE group, 104 of 109 [95.4%] vs SCS, 102 of 110 [92.7%]). Post hoc analyses showed numerically less graft loss due to NAS after HOPE (4 vs 1) and less major complications (Clavien-Dindo classification ≥IIIa) per patient, respectively. Conclusions and Relevance Back-to-base portal-venous HOPE was compared with SCS alone for extended risk DBD and DCD livers. The HOPE approach was safe and associated with reduced EAD, MEAF score, and LOS. These findings support the use of HOPE as a pragmatic strategy to improve early posttransplant outcomes. Trial Registration ClinicalTrials.gov Identifier: NCT05045794 .
Impact of repeated ovulation induction and superovulation on ovarian reserve and early embryo development in obese and PCOS-like mouse models
Kunhiraman, Jyolsna Ponnaratta, Dcunha, Reyon, Madhvacharya, Vanishree Vasave , R, Vani Lakshmi, Venkatraman, Ganesh, Shah, Nidhi Rajesh, Kumar, Anujith , Adiga, Satish Kumar , Kalthur, Guruprasad , Kalthur, Guruprasad , Adiga, Satish Kumar , R, Vani Lakshmi , Venkatraman, Ganesh , Kannan, Nagarajan

Mayo Clinic

Reproduction, Fertility and Development | May 14, 2026 | Volume: 38 | Issue: 8 | Pages: No page available

10.1071/rd26037 | PMID 42128672 Get It

Context Women with obesity or polycystic ovary syndrome (PCOS) often require repeated ovulation induction (OI) due to ovulatory dysfunction and infertility. However, the cumulative effects of repeated stimulation on ovarian function and embryo development remain poorly understood. Aims The present study aimed to understand the consequences of repeated OI and/or repeated superovulation (SO) on preimplantation embryonic development in obese (high-fat diet-induced) and PCOS (high-fat diet and dehydroepiandrosterone-induced) mouse models. Methods Control (without any metabolic disorder), obese, and PCOS mice were divided into three experimental groups. The mice in one round of superovulation (SO1) were injected with 5 IU intraperitoneal (i.p.) injection of pregnant mare serum gonadotropin, followed by 10 IU of human chorionic gonadotropin 48 h later. In the repeated superovulation (SO3) group, mice were subjected to three rounds of superovulation with a gap of 9 days between each superovulation. Mice in the OI3 + SO3 group were administered with three doses of CC (50 mg/kg body weight, i.p., gap of 9 days between each CC injection), followed by three rounds of superovulation. Key results Both single and three rounds of superovulation resulted in decrease in primordial follicles and a moderate increase in atretic follicles in obese and PCOS mice. Reduction in the number of ovulated oocytes, increased rate of abnormal fertilization, decrease in blastocyst rate and elevated DNA damage in blastocysts were observed in in vitro fertilization-derived embryos. Conclusions These findings demonstrate compromised embryonic development following repeated ovarian stimulation. Implications The study highlights need for mild ovarian stimulation strategies in metabolically compromised patients undergoing infertility treatments.
Presacral tumours: international consensus on diagnosis and management
Perry, William R G, Brown, KF, Burns, Elaine, Frizelle, Frank, Glover, Thomas , Glyn, Tamara , Heriot, Alexander, Merchea, Amit , Quyn, Aaron, Sagar, P., Thomas, Gregory, Tiernan, Jim , Turner, Gregory A., Warrier, Satish, Wood, Verity, Group, the Presacral Tumour Working, Cerkaukaite, Dovile, Khan, Ayman , Koneru, S R, Vu, J, Jenkins, John T. , Dozois, E, Heriot, Alexander G. , Perry, William , Perry, William R , Heriot, Alexander , Merchea, Amit , Sagar, Peter , Solomon, Michael J , Burns, Elaine Marie , Denost, Quentin , Graham, Rondell P. , Solomon, Michael J. , Turner, Gregory A, Wood, Verity , Koneru, Sireesha, Litchinko, Alexis , Dozois, Eric J.

Mayo Clinic

British Journal of Surgery | April 28, 2026 | Volume: 113 | Issue: 5 | Pages: No page available

10.1093/bjs/znag053 | PMID 42049258 Get It

Abstract Background Presacral tumours are rare and heterogeneous lesions arising within a complex anatomical space, resulting in variability in diagnosis and management. Increasing incidental detection and evolving surgical and oncological strategies have highlighted the need for contemporary guidance. The aim of this study was to establish an international expert consensus on the optimal diagnosis and management of presacral tumours. Methods An international panel of colorectal surgeons from high-volume units was convened. Evidence- and practice-based statements were developed after domain-based literature reviews and refined through five online and two in-person meetings. Consensus was achieved using a modified Delphi process with anonymous voting. Results In total, 16 colorectal surgeons participated in the study. Ten domains were identified resulting in the development of 22 statements based on expert opinion and retrospective studies. After two rounds, unanimous (100%) agreement was achieved for all statements. High-resolution MRI with structured synoptic reporting is endorsed as central to risk stratification. Selective image-guided transperineal or parasacral biopsy is recommended for high-risk lesions where histology would alter management. Complete surgical resection is defined as the operative goal, with approach tailored to tumour biology and anatomy; minimally invasive surgery is considered appropriate in selected cases. Non-operative surveillance is supported for carefully selected asymptomatic, low-risk cystic lesions. Postoperative surveillance is recommended in a risk-adapted manner according to histopathology and margin status. Conclusion This international consensus provides a pragmatic, risk-stratified framework for the multidisciplinary diagnosis and management of presacral tumours. These recommendations aim to reduce practice variation, support decision-making in specialized centres, and inform future prospective collaborative research.
The prevalence and incidence of narcolepsy in the United States: a real-world observational study using a validated narcolepsy case definition
Ghosh, Somraj , Hoffman, Veena , Calingaert, Brian , Plante, David T. , Krahn, Lois E., Cai, Alice, Anthony, Mary S. , Dave, Shreya , Rao, Satish, Crawford, Stephen , Davé, Shreya

Mayo Clinic

SLEEP Advances | April 17, 2026 | Volume: 7 | Issue: 2 | Pages: No page available

10.1093/sleepadvances/zpag043 | PMID 42111657 Get It

Abstract Study Objectives Narcolepsy is a chronic condition affecting the sleep/wake cycle that is challenging to diagnose. Epidemiological data from large US-focused studies remain limited, with no validated claims-based case selection definitions for narcolepsy. We estimated the prevalence/incidence of diagnosed narcolepsy (type 1 [NT1], type 2 [NT2], overall) in an insured US population using validated, claims-based narcolepsy case definitions. Materials and Methods This observational study used HealthVerity administrative claims-linked electronic medical records to develop case definitions identifying individuals with NT1, NT2, and overall narcolepsy from diagnosis, medication, and procedure codes. Claims-based case definition performance (NT1, NT2, overall narcolepsy) was assessed using positive predictive values (PPVs). Prevalence (per 100 000 persons, on December 31, 2023) and annual incidence (per 100 000 person-years [PY], 2020 − 2023) were calculated/adjusted using PPVs for each case definition. Results Unadjusted point prevalence among individuals with ≥12 months of continuous enrollment were 15.5/100 000 (NT1), 51.1/100 000 (NT2), and 67.0/100 000 (overall narcolepsy). Unadjusted incidence rates were stable from 2020 − 2023 for NT1 (range, 2.0 − 2.3/100 000 PY) but declined across years for NT2 (9.1 − 7.6/100 000 PY) and overall narcolepsy (11.3 − 9.6/100 000 PY). PPVs (95% confidence interval) of NT1, NT2, and overall narcolepsy were 0.81 (0.72 − 0.88), 0.84 (0.75 − 0.91), and 0.80 (0.71 − 0.87), contributing to epidemiologic estimates being reduced by ~20% after PPV adjustment. Prevalence and incidence were higher in females than males. Individuals with NT1 were ~ 4 years younger versus NT2. Conclusions Validated definitions for narcolepsy can reduce potential misclassification. Our findings highlight a relatively low NT1 prevalence in the US. In contrast, NT2 prevalence estimates were > 3 times higher than NT1.
Medication adherence in thoracic transplant candidates
Sanborn, D., Pennington, Kelly M., Benzo, Roberto P. , Schneekloth, Terry D. , Erasmus, D , Budev, Marie, Chandrashekaran, Satish, Levine, Deborah J. , Zell, Cassie L., Novotny, Paul J. , Yip, Daniel , Kushwaha, Sudhir S. , Hardaway, Brian , Sanborn, David M, SANBORN, DAVID, Pennington, Kelly M. , Budev, Marie , Lease, Erika D. , Kennedy, Cassie C.

Mayo Clinic

Frontiers in Psychology | March 20, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.3389/fpsyg.2026.1726871 | PMID 41937824 Get It

Background Medication nonadherence has been associated with poor outcomes in transplant recipients yet identifying these behaviors pre-transplant remains challenging. The simplified medication adherence questionnaire (SMAQ) is a brief, reliable instrument to assess medication adherence. The aim of this study was to perform SMAQ testing on thoracic organ candidates and examine correlations between these scores and individual patient factors predicting medication nonadherence. Methods Consenting waitlisted lung, heart, and heart-lung transplant candidates from six thoracic transplant centers were mailed a survey that included demographic information and the Simplified Medication Adherence Questionnaire (SMAQ). Univariate logistic regression analysis was performed to assess association between pre-transplant medication adherence and demographic characteristics, psychosocial factors, and mortality. Results Among 298 participants, 60.7% were medication nonadherent. Nonadherence was associated with some college education (OR: 1.73; CI: 1.06, 2.81), lower positive affect (OR: 0.95; CI: 0.92, 0.99), and higher uncertainty (OR: 1.02; CI: 1.01, 1.04). Higher positivity ratio predicted adherence. Conclusion Identifiable patient-specific characteristics associated with medication nonadherence can be screened for during thoracic transplant evaluation. Interventions aimed at improving these factors during the pre-transplant period may improve clinical post-transplant outcomes, however, larger studies are needed to validate these findings.
International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions
Bremmer, Felix , Collins, Katrina, Acosta, Andres M., Gupta, Sounak, Maclean, Fiona, Meyts, Ewa Rajpert-De, Dieckmann, Klaus-Peter, Kaushal, Seema , Srigley, John R., Daugaard, Gedske , Kristiansen, Glen, Cheng, Liang, Tickoo, Satish K. , Panel, The Members of the ISUP GU Cancer Precursor Consensus, Cheng, Liang , Reis, Henning , Cheng, Liang , Daugaard, Gedske , Colecchia, Maurizio , Collins, Katrina , Gordetsky, Jennifer , Maclean, Fiona M. , Meyts, Ewa Rajpert‐De , Dieckmann, Klaus‐Peter , Adra, Nabil , Gilligan, Timothy D. , Looijenga, Leendert H. J. , Kristiansen, Glen

Mayo Clinic

American Journal of Surgical Pathology | February 23, 2026 | Volume: 50 | Issue: 6 | Pages: e21-e31

10.1097/pas.0000000000002523 | PMID 41724745 Get It

According to the current WHO classification, noninvasive germ cell neoplasia of the testis comprises germ cell neoplasia in situ (GCNIS), specific forms of intratubular germ cell neoplasia, and gonadoblastoma. Because type II germ cell tumors (GCT, type II) arise from GCNIS, accurate detection of precursor lesions is diagnostically important. In preparation for the 2024 International Society of Urological Pathology (ISUP) Consensus Conference on genitourinary precursor lesions, which took place in Florence, Italy, an anonymous survey was distributed to ISUP members to assess current diagnostic practices regarding testicular precursor lesions. The literature and current WHO classification affirm the significance of precursor lesions in testicular tumours. Working Group 4—Precursor Lesions of the Testis—focused on their practical application by individual pathologists rather than establishing consensus from scientific data. There is strong agreement that GCNIS is the preferred and appropriate term for GCT precursor lesions and that its presence should be reported in cases of invasive GCT. Respondents also agree that “seminoma with intratubular nonseminoma” is the appropriate terminology for seminoma with an associated noninvasive nonseminomatous (embryonal carcinoma, yolk sac tumor, trophoblasts, or teratoma) component. Most pathologists prefer to use OCT3/4 as the primary immunohistochemical marker, and a panel was generally not considered necessary. No consensus is reached regarding the requirement for immunohistochemistry to confirm GCT precursor lesions in the testis. Three questions remain open: the value of subtyping intratubular lesions, the immunohistochemical approach to gonadoblastoma, and the criteria distinguishing Sertoli cell nodules from Sertoli cell tumors.
Accelerometric Assessment of Gastric Contractility Using the Atmo Wireless Motility Capsule
Abell, Thomas, Attaluri, Ashok, Chey, William D., Cline, Michael, Gearry, Richard B., Gibson, Peter R., Ho, Vincent, Lee, Allen A., Lembo, Anthony J, Masoud, Amir , McCallum, R, Moshiree, Baharak, Quigley, Eamonn M. M., Sanchez, Mayra, SAROSIEK, IRENE, Stocker, Abigail, Surjanhata, Brian , Kuo, Braden, Lembo, Anthony , Lee, Allen , Ho, Vincent , Hasler, William L. , Gibson, Peter R , Ho, Vincent , Lembo, Anthony , Surjanhata, Brian C , Lee, Allen A , Chey, William D. , Cline, Michael, Gearry, Richard B. , Moshiree, Baharak , Quigley, Eamonn M.M. , Rao, Satish R. , Thwaites, Phoebe A. , Zhou, Jerry , Kuo, Braden

Mayo Clinic

Neurogastroenterology & Motility | February 12, 2026 | Volume: 38 | Issue: 2 | Pages: No page available

10.1111/nmo.70255 | PMID 41672928 Get It

ABSTRACT Background Patients with gastric dysmotility exhibit abnormal transit and reduced contractility, for which quantification is limited with current methodologies. The Atmo Capsule is a wireless motility capsule that measures regional gastrointestinal transit. We tested its technical capabilities to evaluate gastric contractility by detecting changes in capsule acceleration during transit. Methods Data from 91 healthy controls and 182 patients with suspected dysmotility who ingested the Atmo Capsule following a standardized protocol were included. Gastric emptying times (GET) ≥ 5 h were considered delayed. Contraction frequencies (cycles per minute [cpm]) and amplitudes (as arbitrary units [au]) were identified following Fast Fourier Transformation of accelerometer data using 5‐min windows and were assessed in 30‐min windows post‐ingestion (early gastric phase) and before gastric emptying (late gastric phase). Data were compared via ANOVA, using Bonferroni corrections, between healthy controls, patients with normal gastric emptying, and patients with delayed gastric emptying. Key Results Gastric emptying was delayed in 53/182 (29%) patients. Three cpm contraction frequencies were identified across both gastric phases in controls and patients. Contraction amplitudes did not differ between groups in the early gastric phase. In the late phase, mean amplitudes were lower in patients with delayed gastric emptying (6.4 au) compared with subjects with normal gastric emptying (controls, 9.7 au, p < 0.0001; patients, 8.6 au, p < 0.0001). Conclusions & Inference The Atmo Capsule enables precise quantification of gastric contraction profiles, permitting differentiation of normal from pathological motor patterns. Findings of this technical assessment support its potential for evaluating gastric physiology and detecting pathophysiological patterns of gastric dysmotility.